Hipgnosis Songs Fund Limited Asset sale, adviser appointment, notice of results (2573W)
December 11 2023 - 1:00AM
UK Regulatory
TIDMSONG
RNS Number : 2573W
Hipgnosis Songs Fund Limited
11 December 2023
LEI: 213800XJIPNDVKXMOC11
11 December 2023
Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")
Sale of non-core assets, appointment of advisers and notice of
interim results
Sale of None-core Assets
Further to the announcement of 14 September 2023, the Board of
Hipgnosis Songs Fund Limited has completed the sale of c.20,000
songs (the "Songs") for a gross consideration of $23.1 million,
representing approximately 1% by value of the Company's investment
portfolio.
These non-core songs, which are a subset of those identified as
the Second Disposal as set out in September, were bundled with the
iconic Songs acquired by the Company in 2020 as part of Kobalt Fund
One. They require time intensive, ongoing accounting and reporting
obligations and do not all have perpetual ownership rights. Their
eventual sale was part of the Company's acquisition strategy.
The gross consideration reflects a 14.2% discount to the
valuation of the Songs prepared by the Company's Portfolio
Independent Valuer as at 30 September 2023 and represents a 9.6x
Net Publisher Share multiple. Net proceeds are expected to equal
approximately $22.6 million.
The net proceeds of the sale will be used to pay down RCF
drawings, providing the Company with greater headroom under its
future covenant compliance reporting.
Appointment of Advisers
The Company is pleased to announce the appointment of Singer
Capital Markets as sole corporate broker and financial adviser and
Shot Tower Capital, LLC as lead adviser to conduct due diligence on
the Company's assets as part of its strategic review.
Notice of Interim Results
The Company will announce its financial results for the six
months to 30 September 2023 on Tuesday 19 December 2023.
There will be a briefing for analysts and investors at 08:30 on
the day of announcement.
To register to participate, please contact ir@hipgnosissongs.com .
A recording of the call will subsequently be placed on the
Company's website www.hipgnosissongs.com/song-investors/
For further information please contact:
Hipgnosis Songs Fund
Robert Naylor / Sylvia Coleman
Via Singer Capital Markets +44 (0) 20 7496 3000
Hipgnosis Song Management
Merck Mercuriadis
Ben Katovsky +44 (0) 20 4542 1530
Giles Croot (Media) +44 (0) 20 4542 1511
Singer Capital Markets - Corporate Broker
James Moat / Alaina Wong / Angus Campbell
(Corporate Finance)
Alan Geeves / James Waterlow / Sam Greatrex
(Sales) +44 (0) 20 7496 3000
Headland Consultancy - Financial PR
Susanna Voyle / Charlie Twigg +44 (0) 20 3805 4822
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FURTMBBTMTTBTAJ
(END) Dow Jones Newswires
December 11, 2023 02:00 ET (07:00 GMT)
Hipgnosis Songs (LSE:SOND)
Historical Stock Chart
From Nov 2024 to Dec 2024
Hipgnosis Songs (LSE:SOND)
Historical Stock Chart
From Dec 2023 to Dec 2024